{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:32:24Z","timestamp":1792513944905,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04002-x","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:58:00Z","timestamp":1747947480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ascites complications risk factors of decompensated cirrhosis patients: logistic regression and prediction model"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaolong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"1","key":"4002_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/hep.1840070124","volume":"7","author":"P Gin\u00e9s","year":"1987","unstructured":"Gin\u00e9s P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7(1):122\u20138. https:\/\/doi.org\/10.1002\/hep.1840070124.","journal-title":"Hepatology"},{"issue":"11","key":"4002_CR2","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","volume":"4","author":"R Planas","year":"2006","unstructured":"Planas R, Montoliu S, Ballest\u00e9 B, et al. Natural history of patients hospitalized for management of cirrhotic Ascites. Clin Gastroenterol Hepatol. 2006;4(11):1385\u201394. https:\/\/doi.org\/10.1016\/j.cgh.2006.08.007.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4002_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388\u201398. https:\/\/doi.org\/10.1038\/s41575-023-00759-2.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"4002_CR4","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1016\/S2214-109X(22)00047-X","volume":"10","author":"S Vento","year":"2022","unstructured":"Vento S, Cainelli F. Chronic liver diseases must be reduced worldwide: it is time to act. Lancet Glob Health. 2022;10(4):e471\u20132. https:\/\/doi.org\/10.1016\/S2214-109X(22)00047-X.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"4002_CR5","doi-asserted-by":"publisher","first-page":"S1162","DOI":"10.1016\/S0016-5085(16)33925-7","volume":"150","author":"G Cholankeril","year":"2016","unstructured":"Cholankeril G, Hu M, Perumpail RB, Younossi ZM, Ahmed A. Tu1668 the rising economic burden of Cirrhosis-Related complications. Gastroenterology. 2016;150(4):S1162.","journal-title":"Gastroenterology"},{"issue":"18","key":"4002_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2023.5997","volume":"329","author":"EB Tapper","year":"2023","unstructured":"Tapper EB, Parikh ND. Diagnosis and management of cirrhosis and its complications: A review. JAMA. 2023;329(18):1589\u2013602. https:\/\/doi.org\/10.1001\/jama.2023.5997.","journal-title":"JAMA"},{"issue":"2","key":"4002_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2020;5(2):167\u2013228. https:\/\/doi.org\/10.1016\/S2468-1253(19)30342-5.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4002_CR8","doi-asserted-by":"publisher","unstructured":"Paolo, Angeli et al. Mauro Bernardi,C\u00e0ndid Villanueva,. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatology. 2018;69 (2):406\u2013460. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024","DOI":"10.1016\/j.jhep.2018.03.024"},{"issue":"1","key":"4002_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2021.06.018","volume":"76","author":"G D\u2019Amico","year":"2022","unstructured":"D\u2019Amico G, Bernardi M, Angeli P. Towards a new definition of decompensated cirrhosis. J Hepatol. 2022;76(1):202\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.018.","journal-title":"J Hepatol"},{"issue":"4","key":"4002_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.21776\/ub.jkb.2021.031.04.3","volume":"31","author":"RA Pravitasari","year":"2021","unstructured":"Pravitasari RA. Correlation between Ascites and total lymphocyte count with occurrence of hepatic encephalopathy in liver cirrhosis patients. Jurnal Kedokteran Brawijaya. 2021;31(4):216\u20139.","journal-title":"Jurnal Kedokteran Brawijaya"},{"issue":"6","key":"4002_CR11","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(23)03974-4","volume":"164","author":"X Wang","year":"2023","unstructured":"Wang X, Frandah W, Ghavimi S. Sa1513 ALCOHOL-INDUCED CIRRHOSIS ASSOCIATED WITH HIGH RISK OF GI BLEEDING, ASCITES AND HEPATIC ENCEPHALOPATHY THAN NON-ALCOHOL-INDUCED CIRRHOSIS IN US HOSPITALIZED PATIENT. Gastroenterology. 2023;164(6):S\u20131278.","journal-title":"Gastroenterology"},{"issue":"10","key":"4002_CR12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.4254\/wjh.v15.i10.1140","volume":"15","author":"R Arya","year":"2023","unstructured":"Arya R, Kumar R, Kumar T, et al. Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: an often unconsidered mechanism. World J Hepatol. 2023;15(10):1140\u201352. https:\/\/doi.org\/10.4254\/wjh.v15.i10.1140.","journal-title":"World J Hepatol"},{"key":"4002_CR13","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.dld.2019.12.065","volume":"52","author":"M Tufoni","year":"2020","unstructured":"Tufoni M, et al. Long-term albumin therapy is not futile in patients with cirrhosis and uncomplicated Ascites not normalizing on-treatment serum albumin concentration. Dig Liver Disease. 2020;52:e57\u20138.","journal-title":"Dig Liver Disease"},{"issue":"6","key":"4002_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","volume":"57","author":"E Sol\u00e0","year":"2012","unstructured":"Sol\u00e0 E, Watson H, Graupera I, et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol. 2012;57(6):1199\u2013206. https:\/\/doi.org\/10.1016\/j.jhep.2012.07.020.","journal-title":"J Hepatol"},{"issue":"2","key":"4002_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/gastro\/gox010","volume":"5","author":"B Fortune","year":"2017","unstructured":"Fortune B, Cardenas A. Ascites, refractory Ascites and hyponatremia in cirrhosis. Gastroenterol Rep (Oxf). 2017;5(2):104\u201312. https:\/\/doi.org\/10.1093\/gastro\/gox010.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"2","key":"4002_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jhep.2012.03.018","volume":"57","author":"T Serst\u00e9","year":"2012","unstructured":"Serst\u00e9 T, Gustot T, Rautou PE, et al. Severe hyponatremia is a better predictor of mortality than meldna in patients with cirrhosis and refractory Ascites. J Hepatol. 2012;57(2):274\u201380. https:\/\/doi.org\/10.1016\/j.jhep.2012.03.018.","journal-title":"J Hepatol"},{"key":"4002_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejim.2023.07.003","volume":"117","author":"E Pompili","year":"2023","unstructured":"Pompili E, Zaccherini G, Baldassarre M, et al. Albumin administration in internal medicine: A journey between effectiveness and futility. Eur J Intern Med. 2023;117:28\u201337. https:\/\/doi.org\/10.1016\/j.ejim.2023.07.003.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"4002_CR18","first-page":"99","volume":"11","author":"DMesihovi\u0107R Prohi\u0107","year":"2014","unstructured":"Prohi\u0107 DMesihovi\u0107R, Vanis N, et al. Prognostic markers in patients with decompensated cirrhosis. Med Glas (Zenica). 2014;11(1):99\u2013104.","journal-title":"Med Glas (Zenica)"},{"issue":"4","key":"4002_CR19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3350\/cmh.2023.0024","volume":"29","author":"CY Jung","year":"2023","unstructured":"Jung CY, Chang JW. Hepatorenal syndrome: current concepts and future perspectives. Clin Mol Hepatol. 2023;29(4):891\u2013908. https:\/\/doi.org\/10.3350\/cmh.2023.0024.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"4002_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/jgh.14558","volume":"34","author":"LGin\u00e8sP Bossen","year":"2019","unstructured":"Bossen LGin\u00e8sP, Vilstrup H, et al. Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and Ascites. J Gastroenterol Hepatol. 2019;34(5):914\u201320. https:\/\/doi.org\/10.1111\/jgh.14558.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"4002_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cld.2019.07.005","volume":"23","author":"TOG Kovacs","year":"2019","unstructured":"Kovacs TOG, Jensen DM, Varices. Esophageal, gastric, and rectal. Clin Liver Dis. 2019;23(4):625\u201342. https:\/\/doi.org\/10.1016\/j.cld.2019.07.005.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"4002_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jhep.2007.10.008","volume":"48","author":"JG Abraldes","year":"2008","unstructured":"Abraldes JG, Villanueva C, Ba\u00f1ares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with Pharmacologic and endoscopic therapy. J Hepatol. 2008;48(2):229\u201336. https:\/\/doi.org\/10.1016\/j.jhep.2007.10.008.","journal-title":"J Hepatol"},{"issue":"11","key":"4002_CR23","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3748\/wjg.v19.i11.1707","volume":"19","author":"LSGJ Hu","year":"2013","unstructured":"Hu LSGJ, Wang JH. Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol. 2013;19(11):1707\u201317. https:\/\/doi.org\/10.3748\/wjg.v19.i11.1707.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4002_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1124\/jpet.122.001532","volume":"386","author":"AK Jones","year":"2023","unstructured":"Jones AK, Chen H, Ng KJ, et al. Soluble Guanylyl cyclase activator BI 685509 reduces portal hypertension and portosystemic shunting in a rat Thioacetamide-Induced cirrhosis model. J Pharmacol Exp Ther. 2023;386(1):70\u20139. https:\/\/doi.org\/10.1124\/jpet.122.001532.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"4002_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8(5):1151\u20137. https:\/\/doi.org\/10.1002\/hep.1840080532.","journal-title":"Hepatology"},{"issue":"4","key":"4002_CR26","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/hep.31153","volume":"72","author":"CE Niehaus","year":"2020","unstructured":"Niehaus CE, Strunz B, Cornillet M, et al. MAIT cells are enriched and highly functional in Ascites of patients with decompensated liver cirrhosis. Hepatology. 2020;72(4):1378\u201393. https:\/\/doi.org\/10.1002\/hep.31153.","journal-title":"Hepatology"},{"issue":"4","key":"4002_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cld.2019.06.002","volume":"23","author":"D Adebayo","year":"2019","unstructured":"Adebayo D, Neong SF,Wong F. Ascites and hepatorenal syndrome. Clin Liver Dis. 2019;23(4):659\u201382. https:\/\/doi.org\/10.1016\/j.cld.2019.06.002.","journal-title":"Clin Liver Dis"},{"issue":"8","key":"4002_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMra2215289","volume":"388","author":"MK Nadim","year":"2023","unstructured":"Nadim MK, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis. N Engl J Med. 2023;388(8):733\u201345. https:\/\/doi.org\/10.1056\/NEJMra2215289.","journal-title":"N Engl J Med"},{"issue":"10","key":"4002_CR29","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1111\/liv.13738","volume":"38","author":"F Wong","year":"2018","unstructured":"Wong F, Jepsen P, Watson H, et al. Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and Ascites. Liver Int. 2018;38(10):1785\u201392. https:\/\/doi.org\/10.1111\/liv.13738.","journal-title":"Liver Int"},{"issue":"8","key":"4002_CR30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1478-3231.2010.02293.x","volume":"30","author":"M Guevara","year":"2010","unstructured":"Guevara M, Baccaro ME,R\u00edos J, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int. 2010;30(8):1137\u201342. https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02293.x.","journal-title":"Liver Int"},{"key":"4002_CR31","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.jceh.2017.01.061","volume":"7","author":"L Bossen","year":"2017","unstructured":"Bossen L, Gin\u00e8s P, Vilstrup H, Watson H, Jepsen P. The association between serum sodium and rate of hepatic encephalopathy in cirrhosis patients with Ascites. J Clin Experimental Hepatol. 2017;7:S46\u20137.","journal-title":"J Clin Experimental Hepatol"},{"issue":"4","key":"4002_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000503559","volume":"38","author":"I Bellos","year":"2020","unstructured":"Bellos I, Kontzoglou K, Psyrri A, et al. Tolvaptan response improves overall survival in patients with refractory ascites: A Meta-Analysis. Dig Dis. 2020;38(4):320\u20138. https:\/\/doi.org\/10.1159\/000503559.","journal-title":"Dig Dis"},{"issue":"6","key":"4002_CR33","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jhep.2022.03.005","volume":"76","author":"P Caraceni","year":"2022","unstructured":"Caraceni P, O\u2019Brien A, Gines P. Long-term albumin treatment in patients with cirrhosis and Ascites. J Hepatol. 2022;76(6):1306\u201317. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.005.","journal-title":"J Hepatol"},{"issue":"1","key":"4002_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/hep.26021","volume":"57","author":"A Bortoluzzi","year":"2013","unstructured":"Bortoluzzi A, Ceolotto G, Gola E, et al. Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms. Hepatology. 2013;57(1):266\u201376. https:\/\/doi.org\/10.1002\/hep.26021.","journal-title":"Hepatology"},{"issue":"5","key":"4002_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm.3516","volume":"20","author":"AJ O\u2019Brien","year":"2014","unstructured":"O\u2019Brien AJ, Fullerton JN, Massey KA, et al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014;20(5):518\u201323. https:\/\/doi.org\/10.1038\/nm.3516.","journal-title":"Nat Med"},{"issue":"1","key":"4002_CR36","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","volume":"42","author":"F Durand","year":"2005","unstructured":"Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(1):S100\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2004.11.015.","journal-title":"J Hepatol"},{"issue":"10","key":"4002_CR37","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/apt.17972","volume":"59","author":"D Adebayo","year":"2024","unstructured":"Adebayo D, Wong F. Review Article: recent advances in Ascites and acute kidney injury management in cirrhosis. Aliment Pharmacol Ther. 2024;59(10):1196\u2013211. https:\/\/doi.org\/10.1111\/apt.17972.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"4002_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1756283X14564673","volume":"8","author":"K Lenz","year":"2015","unstructured":"Lenz K, Buder R, Kapun L, et al. Treatment and management of Ascites and hepatorenal syndrome: an update. Th Adv Gastroenterol. 2015;8(2):83\u2013100. https:\/\/doi.org\/10.1177\/1756283X14564673.","journal-title":"Th Adv Gastroenterol"},{"issue":"10","key":"4002_CR39","doi-asserted-by":"publisher","first-page":"e0186301","DOI":"10.1371\/journal.pone.0186301","volume":"12","author":"U Kartoun","year":"2017","unstructured":"Kartoun U, Corey KE, Simon TG, et al. The MELD-Plus: A generalizable prediction risk score in cirrhosis. PLoS ONE. 2017;12(10):e0186301. https:\/\/doi.org\/10.1371\/journal.pone.0186301.","journal-title":"PLoS ONE"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04002-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:58:00Z","timestamp":1747947480000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04002-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4002"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04002-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine approved this study (I2024213), and informed consent was obtained from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}